Transforming Precision Lung Cancer Care: Expert Guidance on HER2-, HER3-, TROP2-, and B7-H3–Targeted ADCs

Content Format:

Video

Credit Type:

AMA | EBAC®

Credits:

1.50
Transforming Precision Lung Cancer Care: Expert Guidance on HER2-, HER3-, TROP2-, and B7-H3-Targeted ADCs

Content Format:

Credits Only

Credit Type:

AMA | EBAC®

Credits:

1.50
Antibody–Drug Conjugates in EGFR-Mutated NSCLC

Content Format:

Slideset

Credit Type:

--

Credits:

--
Mapping TROP-2–Targeted ADCs Into the NSCLC Treatment Landscape

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
TROP-2–Targeted ADCs for NSCLC: ​Integrating a New Therapeutic Option

Content Format:

Video

Credit Type:

AMA | EBAC®

Credits:

1.25
Latest Therapeutic Advancements in Targeting TROP-2 in NSCLC

Content Format:

Slideset

Credit Type:

--

Credits:

--
Optimizing NSCLC Treatment: Potential of ADCs Targeting HER2, HER3, and TROP-2

Content Format:

Video

Credit Type:

AMA

Credits:

1.50
A Year in Review: ADCs Targeting HER3 in NSCLC

Content Format:

Slideset

Credit Type:

--

Credits:

--
Unpacking the Potential of HER3-Targeted Therapy in NSCLC

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Current Considerations for Adverse Event Management With HER3-Directed Agents

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Recent Advances in ADCs and Rationale for HER3 as a Target in Lung Cancer

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Congress to Clinic: Continual Evolution of HER3-Targeting in NSCLC With Expert Perspectives on Clinical Advances and Practical Application

Content Format:

Slideset

Credit Type:

--

Credits:

--
HER3-Targeted Antibody–Drug Conjugates for Lung and Breast Cancers: Where We Are Today

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
2023 World Conference on Lung Cancer Preview: Experts Choose the Top Abstracts

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
FAQs: Novel Antibody–Drug Conjugates and Other Agents Targeting HER3 in NSCLC

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Current Investigational Treatments Targeting HER3 in EGFR-Positive Post-TKI NSCLC

Content Format:

Slideset

Credit Type:

--

Credits:

--
Practical Insights on Key Data From ESMO 2020 Informing Precision Medicine in NSCLC

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Data From ESMO 2020 Informing Precision Medicine in NSCLC: Podcast Pearls

Content Format:

PDF

Credit Type:

--

Credits:

--